Breast Cancer

Radiation Safe and Effective for Patients with BRCA1 or BRCA2 Mutations

Published in Cancer Weekly, November 7th, 2000

To address concerns of patients and physicians, researchers in the United States and Canada examined whether radiation therapy could be safely delivered to women with early stage breast cancer and BRCA1 or BRCA2 genetic mutations - and found that it can.

Some women with these mutations reject radiation therapy in favor of more radical treatments such as mastectomy, because of concerns of the effects of radiotherapy in women who carry a mutation and also of the outcome following treatment.

"Since radiation is known to cause DNA damage, the concern was that the presence of a BRCA1 or BRCA2 breast cancer susceptibility gene would result in a greater...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-11-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry